Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Geroscience|June 23, 2026
Exploratory plasma metabolomics of aging-related associations with muscle quality and pulmonary functionC Navas-Enamorado, X Capo, A Sánchez-Polo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2003
Lymphocytic hypophysitis successfully treated with azathioprine: first case reportA Lecube, G Francisco, D Rodríguez, et al.
Medicina Clinica|June 10, 2000
[Diagnostic performance of serum thyroglobin and iodide-131 Na scan according to the type of recurrence in differentiated thyroid carcinoma]C Zafon, P Galofré, C Hernández, et al.
Nature Communications|March 19, 2025
Marine biogenic humic substances control iron biogeochemistry across the Southern OceanC S Hassler, R Simó, S E Fawcett, et al.
Diabetes Care|April 6, 2001
Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control studyC Hernández, R Burgos, A Cantón, et al.
Revista Clinica Espanola|May 1, 1993
[Platelet hyperactivity in diabetic retinopathy: etiologic factor or epiphenomenon of microangiopathy?]L García Pascual, R Simó, J Monasterio, et al.
Clinical Endocrinology|November 3, 1998
Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal AdenomaJ M Fernández-Real, W R Engel, R Simó, et al.
The British Journal of Ophthalmology|June 30, 2000
Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathyA Cantón, R Burgos, C Hernández, et al.
Histopathology|January 16, 2007
Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinomaC Zafon, G Obiols, J Castellví, et al.
Diabetologia|September 23, 1997
Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathyR Burgos, R Simó, L Audí, et al.
Pageof 10